Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
暂无分享,去创建一个
[1] W. Travis. WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .
[2] William J. Howat,et al. Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers , 2014, Methods.
[3] Michael Grunkin,et al. Image analysis of breast cancer HER2 protein expression used in assessment of staining quality , 2014 .
[4] Clive R Taylor,et al. Recommendations for Improved Standardization of Immunohistochemistry , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[5] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[6] Søren Nielsen,et al. Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains , 2012, Breast Cancer Research and Treatment.
[7] Clive R. Taylor,et al. Standardization of Negative Controls in Diagnostic Immunohistochemistry: Recommendations From the International Ad Hoc Expert Panel , 2014, Applied immunohistochemistry & molecular morphology : AIMM.
[8] C. Lindskog,et al. Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers , 2014, Molecular oncology.
[9] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Clive R. Taylor,et al. Standardization of Positive Controls in Diagnostic Immunohistochemistry: Recommendations From the International Ad Hoc Expert Committee , 2015, Applied immunohistochemistry & molecular morphology : AIMM.
[11] M. Vyberg,et al. Demonstration of CDX2 is Highly Antibody Dependant , 2012, Applied immunohistochemistry & molecular morphology : AIMM.
[12] David R. Jones,et al. Reevaluation and Reclassification of Resected Lung Carcinomas Originally Diagnosed as Squamous Cell Carcinoma Using Immunohistochemical Analysis , 2015, The American journal of surgical pathology.
[13] B. Gilks,et al. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. , 2010, American journal of clinical pathology.
[14] J. Papadimitriou,et al. The total test approach to standardization of immunohistochemistry. , 2009, Archives of pathology & laboratory medicine.
[15] J. Rüschoff,et al. Proficiency testing of immunohistochemical biomarker assays in breast cancer , 2008, Virchows Archiv.
[16] Clive R Taylor,et al. Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry , 2008, Applied immunohistochemistry & molecular morphology : AIMM.
[17] Richard Berendt,et al. Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experience , 2011, Journal of Clinical Pathology.
[18] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.